
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
CooperCompanies has demonstrated a robust financial performance with an annual operating margin increase to 27.0%, surpassing consensus expectations, which positions the company favorably for future profitability. The firm has projected a significant boost in free cash flow for FY26, expecting levels of $575-625 million, marking a year-over-year increase of 33-44%. Additionally, the company's products, particularly the Paragard IUD and its contact lens segment CooperVision, are witnessing strong demand and consistent growth, further supporting a positive outlook for overall revenue and margin enhancement.
Bears say
Cooper Companies is experiencing a modest downward revision in its FY26 revenue growth estimate, shifting from 5.3% to 4.9%, indicating potential challenges in maintaining momentum. The company's gross margin has declined by 80 basis points year-over-year to 66.2%, missing consensus expectations, and this is attributed to tariffs and product mix issues, despite some mitigation from favorable foreign exchange rates. Furthermore, the significant decline in CooperVision's performance in China, with a 28% drop attributed to ongoing weakness in the e-commerce channel, underscores the competitive pressures facing the company that could adversely affect earnings per share growth in FY27.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares